Koreth, J., Munoz, M. C. M., Pantin, J., Arslan, S., Sanz, J., Loren, A., Rambaldi, B., Sala, E., Shimoni, A., Zuckerman, T., Cutler, C., Acevedo, L., Phenis, K., Sun, E., Connelly, S., Rothman, J. (2025). Primary results from Equator, a Phase 3 double-blind, randomized placebo-controlled study evaluating itolizumab in combination with corticosteroids as initial treatment of acute graft-versus-host disease.. Blood. https://doi.org/10.1182/blood-2025-274